The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: A multicenter, randomized, double-blind, controlled trial

Transfusion

Volumn 36, Issue 1, 1996, Pages 29-36

  Price, T H ^a,b   Goodnough, L T ^c   Vogler, W R ^d   Sacher, R A ^e,f   Hellman, R M ^g,h   Johnston, M F M ⁱ   Bolgiano, D C ^b   Abels, R I ^j  

^a UNIVERSITY OF WASHINGTON   (United States)

^b PUGET SOUND BLOOD CENTER   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Depts of Medicine and Pathology

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g Lawrence and Memorial Hospital   (United States)

^h UNIVERSITY OF CONNECTICUT   (United States)

ⁱ S LOUIS UNIV HLTH SCIENCES CENTER   (United States)

^j R W JOHNSON PHARMACEUTICAL RES I   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; RECOMBINANT ERYTHROPOIETIN;

ADULT; AGED; ARTICLE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORTHOPEDIC SURGERY; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT;

EID: 0030063312     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36196190512.x     Document Type: Article

References (27)

1. Toy PT, Strauss RG, Stehling LC, et al. Predeposited autologous blood for elective surgery. A national multicenter study. N Engl J Med 1987;316:517-20.
2. Wallace EL, Surgenor DM, Hao HS, et al. Collection and transfusion of blood and blood components in the United States, 1989. Transfusion 1993;33:139-44.
3. Love TR, Hendren WG, O'Keefe DD, Daggett WM. Transfusion of predonated autologous blood in elective cardiac surgery. Ann Thorac Surg 1987;43:508-12.
4. Britton LW, Eastlund DT, Dziuban SW, et al. Predonated autologous blood use in elective cardiac surgery. Ann Thorac Surg 1989;47:529-32.
5. Owings DV, Kruskall MS, Thurer RL, Donovan LM. Autologous blood donations prior to elective cardiac surgery. Safety and effect on subsequent blood use. JAMA 1989;262:1963-8.
6. Goodnough LT, Shafron D, Marcus RE. The impact of preoperative autologous blood donation on orthopaedic surgical practice. Vox Sang 1990;59:65-9.
7. Zussa C, Polesel E, Salvador L, et al. Efficacy and safety of predeposit blood autodonation in 500 cases of myocardial revascularization. Scand J Thorac Cardiovasc Surg 1990;24:171-5.
8. Goldfinger D, Capon S, Czer L, et al. Safety and efficacy of preoperative donation of blood for autologous use by patients with end-stage heart or lung disease who are awaiting organ transplantation. Transfusion 1993;33:336-40.
9. Kruskall MS, Glazer EE, Leonard SS, et al. Utilization and effectiveness of a hospital autologous preoperative blood donor program. Transfusion 1986;26:335-40.
10. Goodnough LT, Wasman J, Corlucci K, Chemosky A. Limitations to donating adequate autologous blood prior to elective orthopedic surgery. Arch Surg 1989;124:494-6.
11. Goodnough LT, Brittenham GM. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs. J Lab Clin Med 1990;115:28-35.
12. Kickler TS, Spivak JL. Effect of repeated whole blood donations on serum immunoreactive erythropoietin levels in autologous donors. JAMA 1988;260:65-7.
13. Lorentz A, Eckardt KU, Osswald PM, Duchow JR. Erythropoietin levels in patients depositing autologous blood in short intervals. Ann Hematol 1992;64:281-5
14. Goodnough LT, Rudnick S, Price TH, et al. Increased preoperative collection of autologous blood with recombinant human erythropoietin therapy. N Engl J Med 1989;321:1163-8.
15. Thompson FL, Powers JS, Graber SE, Krantz SB. Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease. Am J Med 1991;90:398-400.
16. Watanabe Y, Fuse K, Naruse Y, et al. Subcutaneous use of erythropoietin in heart surgery. Ann Thorac Surg 1992;54:479-84.
17. Kulier AH, Gombotz H, Fuchs G, et al. Subcutaneous recombinant human erythropoietin and autologous blood donation before coronary artery bypass surgery. Anesth Analg 1993;76:102-6.
18. Mercuriali F, Zanella A, Barosi G, et al. Use of erythropoietin to increase the volume of autologous blood donated by orthopedic patients. Transfusion 1993;33:55-60.
19. Goodnough LT, Price TH, Friedman KD, et al. A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion 1994;34:66-71.
20. Beris P, Mermillod B, Levy G, et al. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. A prospective study. Vox Sang 1993;65:212-8.
21. Hayashi J, Kumon K, Takanashi S, et al. Subcutaneous administration of recombinant human erythropoietin before cardiac surgery: a double-blind, multicenter trial in Japan. Transfusion 1994;34:142-6.
22. Goodnough LT, Price TH, Rudnick S, Soegiarso RW. Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapy. Transfusion 1992;32:441-5.
23. Tasaki T, Ohto H, Hashimoto C, et al. Recombinant human erythropoietin for autologous blood donation: effects on perioperative red-blood-cell and serum erythropoietin production. Lancet 1992;339:773-5.
24. Mercuriali F, Gualtieri G, Sinigaglia L, et al. Use of recombinant human erythropoietin to assist autologous blood donation by anemic rheumatoid arthritis patients undergoing major orthopedic surgery. Transfusion 1994;34:501-6.
25. Biesma DH, Marx JJ, Kraaijenhagen RJ, et al. Lower homologous blood requirement in autologous blood donors after treatment with recombinant human erythropoietin. Lancet 1994;344:367-70
26. Nadler SB, Hidalgo JU, Bloch T. Prediction of blood volume in normal human adults. Surgery 1962;51:224-32.
27. Chaplin H Jr, Mollison PL, Vetter H. The body/venous hematocrit ratio: its constancy over a wide hematocrit range. J Clin Invest 1953;32:1309-16.